4//SEC Filing
Mattessich Antony C. 4
Accession 0001104659-24-011195
CIK 0001393434other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:26 PM ET
Size
10.8 KB
Accession
0001104659-24-011195
Insider Transaction Report
Form 4
Mattessich Antony C.
DirectorPresident and C.E.O.
Transactions
- Award
Stock Option (Right to Buy)
2024-02-03+549,400→ 549,400 totalExercise: $5.18Exp: 2034-02-02→ Common Stock (549,400 underlying) - Sale
Common Stock
2024-02-05$4.86/sh+19,642$95,460→ 588,701 total - Award
Common Stock
2024-02-03+180,400→ 608,343 total
Holdings
- 6,500(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]On February 3, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Represents shares of common stock of the Corporation sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 3, 2024. The sales do not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.72 to $4.94, inclusive. The reporting person undertakes to provide to the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.
Documents
Issuer
OCULAR THERAPEUTIX, INC
CIK 0001393434
Entity typeother
Related Parties
1- filerCIK 0001709900
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:26 PM ET
- Size
- 10.8 KB